Company: OXLCZ
Filing Date: 2025-05-20
Form Type: N-CSR
Source: 0001213900-25-045605
Chunk: 33

Company: Oxford Lane Capital Corp.
Filing Date: 2025-05-20
Form: N-CSR
Chunk 33
---
 capital losses related to securities realized after October 31 of a taxable year and prior to the Fund’s fiscal year end (“post -October”) may be deferred as occurring the first day of the following fiscal year. For the fiscal year ended March 31, 2025, the Fund had no post -Octoberlosses to defer. As of March 31, 2025, the estimated components of distributable earnings (accumulated losses) on a tax basis were as follows:

| Distributable ordinary income                                      |     | $ |  131,030,156 |
| Distributable long-term capital gains (capital loss carry forward) |     |   | -138,102,229 |
| Unrealized depreciation on investments*                            |     |   | -667,241,397 |
| Other timing differences                                           |     |   |         -753 |

____________ *The difference between book basis and tax basis unrealized appreciation/(depreciation) is due to the Fund’s CLO equity and partnership investments.

45

OXFORD LANE CAPITAL CORP.
NOTES TO FINANCIAL STATEMENTS
MARCH 31, 2025 NOTE 6. DISTRIBUTIONS (cont.) As of March 31, 2025, the effect of permanent “book/tax” reclassifications resulted in the following increase/(decrease) to the components of net assets:

| Total distributable earnings/(accumulated losses) |     | $ |  2,483,434 |
| Paid-In-Capital                                   |     |   | -2,483,434 |

These differences are primarily due to the CLO equity investments, partnership investments, and non -deductibleexcise tax paid. As of March 31, 2025, the aggregate gross unrealized appreciation for tax purposes was $44,989,314 and aggregate gross unrealized depreciation was $712,230,711. For tax purposes, the cost basis of the portfolio investments at March 31, 2025 was $3,186,669,665. NOTE 7. MANDATORILY REDEEMABLE PREFERRED STOCK The Fund has authorized 50 million shares of mandatorily redeemable preferred stock, at a par value of $0.01 per share, and had 8,761,706shares issued and outstanding at March 31, 2025. During the fiscal year ended March 31, 2025, the Fund had the following series of preferred stock outstanding: 6.75